Bye bye, bifocals? New eye drops can fix farsightedness
Posted:
The US Food and Drug Administration has approved the first eye drop that could allow users to ditch their bifocals—or at least rely on them far less often. Developed by the pharmaceutical company LENZ, VIZZ is an aceclidine ophthalmic treatment in the form of once-daily drops that ease near-object blurriness for up to 10 hours.
From AI-powered healthcare platforms to virtual hospitals, Abto Software is advancing the future of digital health
Healthcare is undergoing a rapid transformation, with technology playing a vital role in improving access to care, supporting clinicians, and enabling more personalised patient…
Healthcare systems around the world are undergoing a fundamental transformation. As demand for care increases and health challenges become more complex, organisations are looking for new ways to connect information, improve collaboration and support better outcomes for both patients and…